 VANCOUVER, British Columbia, April 19, 2022 GLOBE NEWSWIRE -- InMed Pharmaceuticals Inc. InMed or the Company Nasdaq: INM, a leader in the research, development, manufacturing and commercialization of rare cannabinoids, announces that the Companys executive team will be participating in several investor events throughout April and May 2022. 